Evidence map›Paper›PMID 41014216›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2025

Substrate Stiffness Modulates Fibroblast Extracellular Vesicle Secretion Via Mechanotransduction Pathways.

Jun Yang, Lara Ece Celebi, Lauren Hawthorne, S Gulberk Ozcebe, Pinar Zorlutuna

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Jun YangDepartment of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, IN, 46556, USA.
Lara Ece CelebiDepartment of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, IN, 46556, USA.ORCID 0009-0006-6263-246X
Lauren HawthorneDepartment of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, IN, 46556, USA.
S Gulberk OzcebeDepartment of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, IN, 46556, USA.
Pinar ZorlutunaDepartment of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, IN, 46556, USA.ORCID 0000-0002-3122-7553

Funding

Engineered hybrid aging model for disease progressionR01CA275423 · NCI · UNIVERSITY OF NOTRE DAME · PI Pinar Zorlutuna · 2023 to 2026
$1.8M
NCI NIH HHS 1R01CA275423-01A1NCI NIH HHS R01 CA275423
6 · The paper itself

Abstract

The extracellular matrix (ECM) is recognized as a key regulator of cell behavior, with its stiffness playing a crucial role in the progression of pathological conditions such as cancer and cardiovascular diseases. While extracellular vesicles (EVs) are essential mediators of intercellular communication, the influence of matrix stiffness on EV secretion remains poorly understood. This study investigates how substrate stiffness affects EV size and composition in mouse mammary and cardiac fibroblasts, the key stromal cell types in breast cancer and cardiac microenvironments. Importantly, stiffness-tuned EV proteomic cargo is uncovered, providing new insights into how mechanical cues can reprogram the signaling functions of fibroblast-derived vesicles. The findings show that substrate stiffness significantly alters EV characteristics, with sizes increasing below stiffnesses of 20 kPa and decreasing on stiffer substrates. Mechanotransduction pathways involving p53 and thioredoxin are identified as regulators of these alterations, with thioredoxin dominate the modulation in mammary fibroblasts and p53 in cardiac fibroblasts. These results underscore the importance of ECM stiffness in modulating EV secretion and highlight candidate pathways influenced by ECM remodeling that may warrant further investigation for therapeutic relevance.

Indexed as

Extracellular VesiclesFibroblastsMechanotransduction, CellularAnimalsExtracellular MatrixFemaleMiceTumor Suppressor Protein p53Tumor Suppressor Protein p53extracellular vesiclemechanotransductionstiffness

Identifiers

PMID41014216
PMCPMC12614139

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.